1. Home
  2. COLM vs RCUS Comparison

COLM vs RCUS Comparison

Compare COLM & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbia Sportswear Company

COLM

Columbia Sportswear Company

HOLD

Current Price

$55.24

Market Cap

2.9B

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$21.51

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COLM
RCUS
Founded
1938
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
1997
2018

Fundamental Metrics

Financial Performance
Metric
COLM
RCUS
Price
$55.24
$21.51
Analyst Decision
Hold
Buy
Analyst Count
8
10
Target Price
$60.86
$29.20
AVG Volume (30 Days)
484.2K
1.1M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
2.17%
N/A
EPS Growth
N/A
N/A
EPS
3.24
N/A
Revenue
$3,042,478,000.00
$247,000,000.00
Revenue This Year
$3.73
N/A
Revenue Next Year
$3.04
$70.88
P/E Ratio
$17.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$47.48
$6.79
52 Week High
$77.97
$26.40

Technical Indicators

Market Signals
Indicator
COLM
RCUS
Relative Strength Index (RSI) 36.97 47.73
Support Level $53.96 $20.35
Resistance Level $58.08 $24.62
Average True Range (ATR) 1.52 1.16
MACD -0.34 -0.13
Stochastic Oscillator 17.17 9.33

Price Performance

Historical Comparison
COLM
RCUS

About COLM Columbia Sportswear Company

Columbia Sportswear Co makes outdoor and active-lifestyle apparel, footwear, equipment, and accessories that it sells under four primary brands: Columbia, Sorel, Mountain Hardwear, and prAna. The majority of sales are in the United States, but the company also has remarkable sales in its three other geographic segments: Latin American and Asia-Pacific; Europe, Middle East, and Africa; and Canada. The majority of sales are through wholesale channels, including sporting goods and department stores, but the company also operates its own branded stores in each of its geographic segments. It sources products from around the world and uses contract manufacturers outside the United States, predominantly in Asia to manufacture its various products.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: